Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Marvell Tech, Lowers Price Target to $41

Morgan Stanley Maintains Equal-Weight on Marvell Tech, Lowers Price Target to $41

Morgan Stanley analyst Joseph Moore maintains Marvell Tech (NASDAQ:MRVL) with a Equal-Weight and lowers the price target from $60 to $41.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Morgan Stanley analyst Joseph Moore maintains Marvell Tech (NASDAQ:MRVL) with a Equal-Weight and lowers the price target from $60 to $41.

Analyst Ratings

Expert Ratings for Clean Harbors

By Benzinga Insights

May 4, 10:01 AM

Within the last quarter, Clean Harbors (NYSE:CLH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

CLH

Tyson Foods Analysts Cut Their Forecasts After Q4 Results

By Lisa Levin

November 14, 3:11 PM

Tyson Foods, Inc. (NYSE: TSN) posted better-than-expected earnings for its fourth quarter on Monday.

TSN

Analyst Ratings

Analyst Ratings for Biomea Fusion

By Benzinga Insights

April 19, 3:02 PM

Over the past 3 months, 13 analysts have published their opinion on Biomea Fusion (NASDAQ:BMEA) stock. These analysts…

BMEA

News

Viemed To Centralize Market For Common Shares On NASDAQ Through Voluntary Delisting From TSX

By Benzinga Newsdesk

December 7, 10:02 AM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced that it has applied and received approval

TSX:VMD

Morgan Stanley Maintains Equal-Weight on Marvell Tech, Lowers Price Target to $41

Related Posts

Expert Ratings for Clean Harbors

Tyson Foods Analysts Cut Their Forecasts After Q4 Results

Analyst Ratings for Biomea Fusion

Viemed To Centralize Market For Common Shares On NASDAQ Through Voluntary Delisting From TSX